Press Releases

Evidence Obtained By Committee Debunks Claim That CyTech Was First to Discover OPM Data Breach

Washington, D.C. (May 26, 2016)—Today, Rep. Elijah E.

Cummings Issues Statement on House Floor Opposing Republican Bill To Repeal the D.C. Budget Autonomy Act

Washington, D.C. (May 25, 2016)—Today, Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, spoke on the House floor in opposition to H.R. 5233, the Clarifying Congressional Intent in Providing for DC Home Rule Act of 2016.

New Report Finds Oracle Corp. "Primarily and Directly Responsible" for Failed Oregon Health Website

Corporate Officials Conceded

Internally That Work Was Deficient

State IG Confirms Longstanding and Widespread Personal Email Use by Secretaries of State and their Staff

Report Finds Clinton Returned Emails, Powell Did Not

Washington, D.C. (May 25, 2016)—Today, Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, issued the following statement in response to a report issued by the Inspector General of the State Department on the email practices of several previous Secretaries of State:

Cummings Objects to Baseless Republican Attacks on IRS Commissioner

After Two Dozen Hearings and More Than

$20 Million, GOP Turns Up Nothing

Washington, D.C. (May 24, 2016)—Today, Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, strongly objected to the continued unsubstantiated attacks against IRS Commissioner John Koskinen by Republican Oversight Committee Members and Members of the Freedom Caucus.

Republicans “Misfire” on Ben Rhodes Hearing

Yesterday, Oversight Committee Chairman Chaffetz rushed to hold a hearing on Republican accusations that White House advisor Ben Rhodes sold a false narrative to the American people about the Iran nuclear agreement.

Michigan Governor's Responses to Congress Raise New Concerns About His Testimony

Snyder Now Admits Emails May Have Been Deleted, Repeatedly Claims He Does Not Recall Basic Facts

Cummings Issues Statement on Valeant's Pricing Changes

Washington, D.C. (May 16, 2016)—Today, Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, issued the following statement after Valeant Pharmaceuticals' new CEO, Joseph Papa, announced a plan to offer rebates for two of its hospital-administered heart drugs, Isuprel and Nitropress: